Ocular Therapeutix (OCUL) Prepaid Assets (2013 - 2026)
Ocular Therapeutix's (OCUL) quarterly Prepaid Assets came in at $11.2 million in Q1 2026, up 17.74% year-on-year from $9.5 million in Q1 2025, and up 3.29% quarter-over-quarter from $10.9 million in Q4 2025.
Ocular Therapeutix (OCUL) Prepaid Assets (2013 - 2026) Analysis & Trends
Ocular Therapeutix's Prepaid Assets history runs 14 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 17.74% year-over-year to $11.2 million in Q1 2026; TTM through Mar 2026 was $11.2 million, a 17.74% increase from a year earlier, with the FY2025 full-year figure at $10.9 million, down 19.34% from the prior year.
- Prepaid Assets grew to $11.2 million in Q1 2026 per OCUL's latest filing, from $10.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $13.5 million in Q4 2024 and bottomed at $3.3 million in Q3 2022.
- The 5-year median for Prepaid Assets is $7.7 million (2024), against an average of $7.4 million.
- Across the five-year window, Prepaid Assets surged 170.49% in 2024 and tumbled 39.53% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $4.0 million in 2022, then jumped by 93.5% to $7.8 million in 2023, then jumped by 72.66% to $13.5 million in 2024, then decreased by 19.34% to $10.9 million in 2025, then gained by 3.29% to $11.2 million in 2026.
- Per Business Quant, the three latest OCUL Prepaid Assets figures stand at $11.2 million (Q1 2026), $10.9 million (Q4 2025), and $8.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocular Therapeutix | 1.93 Bn | 1.93 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.21 Mn |
| Dec 31, 2025 | 10.86 Mn |
| Sep 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 8.79 Mn |
| Mar 31, 2025 | 9.52 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | 13.15 Mn |
| Jun 30, 2024 | 6.12 Mn |
| Mar 31, 2024 | 7.67 Mn |
| Dec 31, 2023 | 7.79 Mn |
| Sep 30, 2023 | 4.86 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.03 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 4.67 Mn |
| Dec 31, 2021 | 4.75 Mn |
| Sep 30, 2021 | 3.88 Mn |
| Jun 30, 2021 | 4.82 Mn |